What is the significance of asymptomatic CK elevation in combination therapy of hyperlipidemia with statin/Niaspan (niacin extended-release tablets)? I have a patient whose lipids were suboptimally ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has dosed the first subjects in a Phase 1/2a clinical trial of ARO-DIMER-PA, the company’s investigational RNA interference (RNAi ...

Researchers have uncovered a simple magnesium-based score that could help identify which high-cholesterol patients are most likely to face deadly heart problems, years before symptoms appear. Study: ...

April 16, 2007 (Seattle) — Simple hypercholesterolemia is different from combined hyperlipidemia, which is associated with obesity and metabolic syndrome, and the two conditions respond somewhat ...

Research led by Baylor College of Medicine has shown that a new therapy significantly reduces triglyceride levels in individuals with mixed hyperlipidemia – elevations of triglycerides and cholesterol ...

DelveInsight’s Hyperlipidemia Market Insights report includes a comprehensive understanding of current treatment practices, hyperlipidemia emerging drugs, market share of individual therapies, and ...

Hyperlipidemia or dyslipidemia is also called high blood cholesterol. Cholesterol is a waxy white fatty molecule which is an essential part of every cell membrane. It is also a building block for many ...

Machine learning models, particularly LightGBM, effectively predict hyperlipidemia in PLWH on HAART for six months, with high accuracy and area under curve values. The study's limitations include ...

Physician and patient predictors of hyperlipidemia screening and statin prescription at a large, multihospital regional health center based on electronic health record data. Objectives: Appropriate ...

Please provide your email address to receive an email when new articles are posted on . “PCOS patients are at increased risk of metabolic conditions, even patients who were in the non-obese range,” ...